Bharat Biotech took to Twitter to allay any concerns over the vaccine, saying trials are based on a two-dose schedule, given 28 days apart

Bharat Biotech took to Twitter to allay any concerns over the vaccine, saying trials are based on a two-dose schedule, given 28 days apart